Shanghai OPM Biosciences Hits Day High with 5.74% Surge in Stock Price

Shanghai OPM Biosciences Co. has experienced a significant uptick in its stock performance, gaining 5.74% on August 10, 2026. The stock reached an intraday high of CNY 71.88, reflecting a strong day of trading for the midcap company in the Pharmaceuticals & Biotechnology sector. Over the past week, Shanghai OPM Biosciences has shown remarkable resilience, with a 37.02% increase compared to the China Shanghai Composite's 4.12%. The company's one-month performance stands at 38.15%, significantly outpacing the composite index, which has seen a decline of 0.74%. Year-to-date, the stock has risen by 36.43%, while the broader market has remained nearly flat. Despite these positive short-term trends, the company has faced challenges in long-term growth, with net sales growing at an annual rate of 6.53% and operating profit declining by 43.06% over the past five years. Nevertheless, recent financial results indicate a turnaround, with operating cash flow reaching CNY 114.81 million and net sales for the first half of the year at CNY 187.85 million, marking a growth of 37.97%.